Home › Bipolar Disorder › Connecticut
Bipolar Disorder clinical trials in Connecticut
3 studies for Bipolar Disorder are looking for participants at sites in Connecticut.
A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)
- Yale University School of Medicine, New Haven
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 22, 2026 · NCT07286175The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal Effects
- VA Connecticut Healthcare System, West Haven
RecruitingPhase 2
Ages 21 to 65 · All sexes · Updated May 6, 2026 · NCT05786066Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
- Hartford Hospital, Hartford
RecruitingObservational study
Ages 18 to 40 · All sexes · Updated Mar 10, 2026 · NCT06740383From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.